Proov, an at-home hormone testing kit company, has announced funding from two venture capital firms that aim to build up underrepresented founders.
The investment – the amount was not disclosed – from Lightship Capital and Texas HALO Fund will help Proov scale in the wake of Covid-19 as the company continues to offer fertility diagnostics technology to the retail market.
MFB Fertility Inc. launched Proov in 2018. Its FDA-approved at-home test measures the presence of progesterone metabolite PdG in urine to help a woman confirm ovulation; low progesterone is the number one cause of infertility and preventable miscarriage. The company was originally co-founded in Boulder, Colorado, by two women who both struggled to conceive.
Because of Covid-19, the